US2022387464A1PendingUtilityA1

Inositol phosphate-containing composition

Assignee: OTSUKA PHARMA CO LTDPriority: Oct 26, 2017Filed: Aug 16, 2022Published: Dec 8, 2022
Est. expiryOct 26, 2037(~11.2 yrs left)· nominal 20-yr term from priority
A61P 9/12A61K 31/6615A61K 31/7028A61P 3/10A61K 9/08A23L 33/10A61K 31/19A61P 1/16A61K 47/12A61P 3/14A23V 2002/00A61K 33/06A61P 19/06A23V 2250/641A61P 43/00A61P 13/02
57
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention further provides a composition for inhibiting purine body absorption, a composition for inhibiting purine nucleotide metabolism, a composition for inhibiting phosphatase, a composition for inhibiting uric acid level elevation, a composition for improving blood pressure, a composition for improving blood glucose level, a composition for improving liver function, a composition for controlling serum iron level, or a composition for promoting calcium absorption, comprising an inositol phosphate or a salt thereof. The present invention further provides a composition comprising an inositol phosphate or a salt thereof, wherein the taste thereof is improved by adding thereto a predetermined amount of calcium lactate.

Claims

exact text as granted — not AI-modified
1 . A method for promoting calcium absorption, comprising administering an effective amount of a composition comprising an inositol phosphate or a salt thereof to a person in need of calcium absorption promotion. 
     
     
         2 . A method for controlling serum iron level, comprising administering an effective amount of a composition comprising an inositol phosphate or a salt thereof to a person in need of serum iron level control. 
     
     
         3 . The method of  claim 1 , wherein said composition further comprises calcium lactate in a weight ratio of inositol phosphate to calcium lactate of 1:0.2 to 1:0.5. 
     
     
         4 . The method of  claim 1 , wherein said composition is liquid. 
     
     
         5 . The method of  claim 2 , wherein said composition further comprises calcium lactate in a weight ratio of inositol phosphate to calcium lactate of 1:0.2 to 1:0.5. 
     
     
         6 . The method of  claim 2 , wherein said composition is liquid.

Join the waitlist — get patent alerts

Track US2022387464A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.